NL-OMON38408已完成不适用
Phase I clinical trial to assess safety and immunogenicity of an MVA-based influenza H5 vaccine in healthy adults - Phase 1 study with an MVA-based influenza H5 vaccine
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •18-35 years of age
- •Female volunteers must acquire an acceptable form of contraception during the study period and to have a negative pregnancy test on the days of immunization.
- •Refrain from blood donation during the study period
- •Written informed consent
- •Able and willing to comply with all study requirements
排除标准
- •Pregnancy or lactation
- •Acute or chronic illness
- •Known allergy to eggs, egg products or chicken protein
- •Previous immunization with a recombinant MVA
- •Previous immunization with an influenza A/H5N1 vaccine
研究者
相似试验
已完成
1 期
A Phase I clinical trial to assess safety and immune response of Influenza vaccine of Serum Institute of India Limited in Adults.CTRI/2011/09/002033Serum Institute of India Ltd Pune India40
已完成
1 期
Study to evaluate safety and possible adverse reactions, especially serious, with a vaccine for measles and rubella in healthy subjects.Measles and RubellaRBR-9hckj4Bio-Manguinhos/Fiocruz/MS
进行中（未招募）
不适用
Phase I and IIa trial to assess the safety, immunogenicity and protective efficacy against sporozoite challenge of the candidate malaria vaccine pfLSA-3 vaccine. - LSA3-trialP. falciparum infection (malaria)EUCTR2006-001743-66-NLINSTITUT PASTEUR, Biomedical Parasitology Unit
招募中
不适用
A Phase I trial to assess safety and immunogenicity of i.d. DNA priming and i.m. MVA boosting in healthy volunteers in MozambiqueHIV/AIDSPACTR201106000304583Swedish Institute for Infectious Disease Control24
招募中
1 期
A phase I trial to assess safety and immunogenicity of an HLAII-targeted DNA vaccine against influenza H7N9Influenza prophylaxisCTIS2022-500706-18-01Oslo University Hospital Hf30